Opportunity Information: Apply for RFA AG 23 024

Policy and Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed) is a National Institutes of Health (NIH) funding opportunity (RFA-AG-23-024) that supports research aimed at understanding why inequities persist in dementia-related health care and what can be learned from real-world policy differences. The focus is on disparities affecting people living with AD/ADRD, specifically disparities in access to care, patterns of service use (utilization), and the quality of care delivered. Rather than funding traditional clinical trials, the announcement prioritizes studies that take advantage of naturally occurring differences in social and health care policies across places and time periods to identify causal mechanisms behind unequal care.

A central idea in this FOA is that policies change, and those changes often do not affect all communities equally. Applicants are encouraged to treat these policy variations as opportunities for rigorous evaluation, using experimental, quasi-experimental, or otherwise innovative research designs. In practice, this could mean analyzing how differences in state Medicaid rules, reimbursement policies, long-term services and supports, caregiver supports, eligibility criteria, workforce policies, telehealth coverage, or other health and social policies shape who receives dementia screening and diagnosis, who can access specialty care and community-based services, how often people are hospitalized or placed in nursing homes, and whether the care they receive meets accepted standards. The goal is not only to document that disparities exist, but to uncover the mechanisms that produce them, which is essential for designing interventions and informing better policy decisions.

The mechanism supported is an NIH Research Project Grant (R01), and the FOA is explicitly labeled "Clinical Trial Not Allowed," signaling that the funded projects should not be clinical intervention trials involving prospective assignment of human participants to interventions. Instead, the research emphasis is on policy and systems-level evaluation, often relying on observational data, natural experiments, and analytic strategies that strengthen causal inference. Competitive proposals would typically be expected to use strong designs such as difference-in-differences, regression discontinuity, instrumental variables, interrupted time series, synthetic controls, or other approaches that can credibly estimate the effects of policies on dementia care outcomes and disparities, while also addressing confounding factors and bias.

Eligibility is broad, reflecting an interest in drawing on expertise from many sectors and ensuring that organizations closely connected to affected communities can lead or partner in the work. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; other tribal organizations; public housing or Indian housing authorities; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (other than small businesses) and small businesses; and other entities. The FOA also explicitly welcomes applications from and involving organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations, regional organizations, U.S. territories or possessions, eligible federal agencies, and even non-U.S. (foreign) entities. This wide net aligns with the reality that dementia care disparities are shaped by community context, service systems, and policy environments, not just clinical settings.

Administratively, this is a discretionary grant opportunity in the health funding category, associated with CFDA number 93.866, and offered by NIH (with the Institute-level focus implied by the "AG" identifier, which corresponds to the National Institute on Aging). The original closing date listed for the opportunity was October 20, 2022, and the posting indicates that an award ceiling and expected number of awards were not specified in the provided summary. The opportunity was created on May 6, 2022, which places it within a period when many federal dementia initiatives were emphasizing equity, real-world evidence, and policy-relevant research.

Overall, the FOA is best understood as a call for rigorous, policy-aware health services and health equity research in AD/ADRD. It aims to move beyond describing disparities toward identifying the policy-driven pathways that create or sustain them, using credible analytic designs and leveraging real-world policy variation to generate evidence that can guide improvements in dementia care access, utilization, and quality for populations that have historically been underserved or disproportionately burdened.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Policy and Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2022-05-06.
  • Applicants must submit their applications by 2022-10-20. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AG 23 024

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Healthcare Providers, Alzheimers Disease Research

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Workshops on Computational and Analytical Research Methods (R25 - Clinical Trial Not Allowed)

Previous opportunity: NIJ FY 2022 Invited to Apply - Byrne Discretionary Community Project Funding/Byrne Discretionary Grants Program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AG 23 024

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AG 23 024) also looked into and applied for these:

Funding Opportunity
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders or Alcohol Use Disorder (U19 Clinical Trial Optional) Apply for PAR 22 144

Funding Number: PAR 22 144
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Short-term Mentored Career Enhancement Award in Dental, Oral, and Craniofacial Research for Mid-Career and Senior Investigators (K18- Independent Clinical Trial Not Allowed) Apply for PAR 22 121

Funding Number: PAR 22 121
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 037

Funding Number: RFA AI 22 037
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed) Apply for RFA HG 22 002

Funding Number: RFA HG 22 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,800,000
Competitive Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Enhance Workforce Diversity in Health Services Research Apply for PA 22 175

Funding Number: PA 22 175
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) Apply for RFA RM 22 020

Funding Number: RFA RM 22 020
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) Apply for RFA NS 22 071

Funding Number: RFA NS 22 071
Agency: National Institutes of Health
Category: Health
Funding Amount: $8,250,000
Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) to Accelerate Diagnostic and Vaccine Development (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 034

Funding Number: RFA AI 22 034
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) Apply for PAR 22 184

Funding Number: PAR 22 184
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed) Apply for RFA NS 22 066

Funding Number: RFA NS 22 066
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Expanding Prevention Strategies for Mental Disorders in Mobile Populations in Humanitarian Crises (R34 Clinical Trial Optional) Apply for RFA MH 22 180

Funding Number: RFA MH 22 180
Agency: National Institutes of Health
Category: Health
Funding Amount: $450,000
NINDS Interdisciplinary Team Science Grant (RM1 Clinical Trial Optional) Apply for RFA NS 22 036

Funding Number: RFA NS 22 036
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed) Apply for PAR 22 186

Funding Number: PAR 22 186
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Maximizing Investigators' Research Award (R35 - Clinical Trial Optional) Apply for PAR 22 180

Funding Number: PAR 22 180
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed) Apply for PAR 22 172

Funding Number: PAR 22 172
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection- Interventions from Small Businesses (U44 Clinical Trial Not Allowed) Apply for RFA NS 22 067

Funding Number: RFA NS 22 067
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Research Education Program (UE5 Clinical Trial Not Allowed) Apply for RFA RM 22 022

Funding Number: RFA RM 22 022
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) Apply for PAR 22 155

Funding Number: PAR 22 155
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,000,000
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Partnership for Innovation Research Projects (U01 Clinical Trial Not Allowed) Apply for RFA RM 22 023

Funding Number: RFA RM 22 023
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed) Apply for PAR 22 185

Funding Number: PAR 22 185
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 23 024", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: